Search results
Moderna ends gene editing alliance with Metagenomi
BioPharma Dive via Yahoo Finance· 1 day agoMetagenomi said the companies’ decision to part ways followed a “strategic prioritization” undertaken by Moderna, which has made several investments in...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 16 hours agoModerna stock broke out for the first time in a year on Thursday after beating Wall Street's...
Moderna Shares Jump After Better-Than-Expected Sales
The Wall Street Journal· 21 hours agoModerna shares shot up about 7% Thursday after reporting better-than-expected quarterly sales and signaling confidence in a sales pickup later this year....
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via AOL· 15 hours agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 14 hours agoModerna (NASDAQ: MRNA) was a fine stock to heal an ailing portfolio on the second-to-last trading day of the week. The company, which developed and sells...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 1 day agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 21 hours agoModerna, Inc. MRNA reported earnings of $3.07 per share in the first quarter of 2024, beating the...
Moderna Focused on Cutting Costs, RSV Vaccine
Bloomberg· 22 hours agoModerna Chief Executive Officer Stéphane Bancel talks about how the biotech giant is cutting costs and developing new vaccines. The drugmaker expects to...
mRNA Is Promising A Breakthrough In Fighting Cancer
Benzinga via AOL· 4 days agoBy the looks of it, this was only the beginning of the healthcare revolution that mRNA triggered. Mainz Biomed N.V. (NASDAQ...
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 20 hours agoImage source: The Motley Fool. Moderna (NASDAQ: MRNA) Q1 2024 Earnings Call May 02, 2024, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers...
